Stem Cell Therapy Market for Parkinson's Begins Phase 1 Trial in 2025 | Most Leading Companies- Mesoblast Ltd, Lineage Cell Therapeutics, Inc., BlueRock Therapeutics LP, Orchard Therapeutics plc., CRISPR Therapeutics AG

The Global Stem Cell Therapy Market reached US$ 16.44 billion in 2024 and is expected to reach US$ 45.69 billion by 2033, growing at a CAGR of 12.7 % during the forecast period 2025-2033.

Stem Cell Therapy Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://www.datamintelligence.com/download-sample/stem-cell-therapy-market?kb

Stem cell therapy is a form of regenerative medicine that uses stem cells to repair or replace damaged tissues and cells in the body. It holds promise for treating conditions like diabetes, Parkinson's disease, heart disease, and spinal cord injuries.

List of the Key Players in the Stem Cell Therapy Market:

Mesoblast Ltd, Lineage Cell Therapeutics, Inc., BlueRock Therapeutics LP, Orchard Therapeutics plc., Vericel Corporation., CRISPR Therapeutics AG, Fate Therapeutics, Inc., Novartis AG, Bristol Myers Squibb (Juno Therapeutics, Inc.), Bluebird bio, Inc., MEDIPOST Co., Ltd., ANTEROGEN.CO., LTD., CORESTEMCHEMON Inc., PHARMICELL Co., Ltd, and JCR Pharmaceuticals Co., Ltd. among others.

Industry Development:

In November 2024, Vertex Pharmaceuticals initiated a pivotal Phase 1/2 clinical trial for VX-264, its investigational stem cell-derived islet therapy designed for individuals with Type 1 diabetes (T1D). This marks a significant step forward in the pursuit of transformative treatments for diabetes management.

In February 2024, San Diego-based biotech firm Kenai Therapeutics secured $82 million in Series A funding to accelerate the development of its cell therapies for Parkinson's disease and other neurological conditions. The round was co-led by Cure Ventures, the Alaska Permanent Fund Corporation, and The Column Group, with support from Euclidean Capital and Saisei Ventures.

Research Process:

Both primary and secondary data sources have been used in the global Stem Cell Therapy Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/stem-cell-therapy-market?kb

Segment Covered in the Stem Cell Therapy Market:

By Therapy Type: Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy

By Cell Source: Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells, Others

By Therapeutic Application: Musculoskeletal Disorders, Neurological Disorders, Autoimmune Diseases, Cardiovascular Diseases, Wounds & Surgeries, Inflammatory, Others

Regional Analysis for Stem Cell Therapy Market:

The regional analysis of the Stem Cell Therapy Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/stem-cell-therapy-market?kb

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Stem Cell Therapy market?

➠ Who are the leading manufacturers in the global Stem Cell Therapy industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Stem Cell Therapy industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Stem Cell Therapy market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.